Updated:
Torreal
Torreal was established in 1990 by Juan Abelló Gallo after the 1987 divestiture of the family pharmaceutical business Antibióticos. Miguel Abelló Gamazo, son...
Torreal
Torreal was established in 1990 by Juan Abelló Gallo after the 1987 divestiture of the family pharmaceutical business Antibióticos. Miguel Abelló Gamazo, son of the founder, holds the role of Executive President while Anna Gamazo Hohenlohe serves as Vice-Chairman. The firm pursues buyouts, growth equity and co-investments in private companies. Confirmed holdings span industrial technology, healthcare services and mobility. Geographic reach covers Europe and North America with additional exposure noted in Africa and South America. TowerBrook Capital Partners has appeared alongside Torreal in aerospace and industrial transactions. Torreal maintains a team of family principals and long-term advisors including Bernardino Diaz-Andreu. The firm holds real-estate assets such as Finca Las Jarillas and Finca El Borril. No operational events from the last 24 months appear in public records. Torreal operates through a concentrated family governance structure with Juan Abelló Gallo retaining the title of Honorary President. Investment decisions remain internal to the Abelló family principals rather than delegated to external managers.
General information
Firm type
Single Family Office
Year founded
1990
AUM
Undisclosed
Location
Region
Europe
Country
Spain
City
Madrid
Corporate office
Madrid, Spain
Principals
Miguel Abelló Gamazo
Executive President
Juan Abelló Gallo
Honorary President
Altss tracks 2 additional named team members for this firm — including direct investment leads, IR, and operating principals not listed on the public website.
Book a demoSector focus
Frequently asked questions
Who runs investment decisions at Torreal?
Miguel Abelló Gamazo holds the title of Executive President. Juan Claudio Abelló Gamazo serves as Partner. Decisions remain within the family principals.
Where does the underlying wealth come from?
Wealth originated from the 1987 sale of Antibióticos, the family pharmaceutical group founded by Juan Abelló Gallo.
Does Torreal participate in fund commitments or only direct deals?
Torreal executes direct co-investments and SPVs. It has partnered with TowerBrook Capital Partners on industrial transactions.
What investment stages does Torreal typically target?
Torreal targets growth and late-stage opportunities. It also executes buyouts and turnaround situations.
Which sectors does Torreal focus on?
Sector exposure includes SpaceTech, ClimateTech, Industrial Tech, Healthcare Services and AgriTech & FoodTech.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: